Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Cohen

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Nature Cancer|July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Research Square|January 9, 2026
Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndromeCaren Latrèche, Valentina Mancini, Marija Dvojakovska, et al.
Nature Communications|July 2, 2025
Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Nature Communications|February 27, 2026
Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Cell|August 5, 2022
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammationSara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Nature Cancer|July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Research Square|January 9, 2026
Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndromeCaren Latrèche, Valentina Mancini, Marija Dvojakovska, et al.
Nature Communications|July 2, 2025
Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Nature Communications|February 27, 2026
Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Cell|August 5, 2022
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammationSara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, et al.
Pageof 9